Granules India shares tumble almost 8% after USFDA issues warning letter for its Gagillapur ...
Granules India's shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing ...
Orchid Pharma shares gain despite USFDA issues seven minor observations
The inspection, which commenced on 10 February 2025 and concluded on 18 February 2025, resulted in seven minor observations, none of which pertain to the data integrity of the facility.